Key result
The evolution of specialist societies into national research networks is proposed as a solution to the translation problem in anaesthetic research, despite cultural and funding barriers.
Answers are grounded in this paper and cite their sources.
Proposes that specialist societies in anaesthesia should evolve into national research networks to better conduct large, multicentre clinical trials and secure funding.
In his excellent editorial on translational research and anaesthesia, Professor Shorten correctly describes that the problem of perception with anaesthetic research is one potential threat to the academic effort of the specialty [1]. National Health Service Research and Development (NHS R & D) takes the view that research for patient benefit is best undertaken by properly organised national research networks, as these can deal efficiently with the (new) issues surrounding research governance, ethics and clinical trials directives [2]. This enables them not only to identify the priorities but also to conduct large, multicentre clinical trials designed to translate developments in the laboratory to the bedside. The ‘added value’ of networks and the funding they can generate can, in turn, fund more basic research as well. In contrast, as Shorten observes, much research in anaesthesia, critical care or pain medicine is conducted by individual or small groups of anaesthetists working in relatively isolated operating theatres or ICUs. To summarise Shorten's point: the perception from the outside is that ‘if you’re not doing research within a network, then your research does not really matter to patients'. Unfortunately, Shorten's article does not expand upon possible solutions to this problem. One solution, offered by the Royal College's Academic Strategy Report (referred to by Shorten), is for anaesthetists to form their own national research networks [3]. It is important to emphasise that NHS R & D offers support to all networks where the relevant specialists have set clear priorities and wish to involve patients in trials for patient benefit, and Section 13 and Appendix G of the Report describes how this might be achieved [3]. The proposed solution is that our specialist societies are the platforms from which these networks can evolve. These consist of highly motivated and experienced NHS consultants and academics. They already possess much of the basic infrastructure required (for example membership databases, funding, annual meetings, and secretarial support) and are ideally placed to identify the priorities for clinical research, trials or equipment development [4]. Unfortunately, our Report also identified some barriers to this potential evolution (detailed in Appendix D, based on feedback from societies themselves) [3]. First, some societies do not view research – even clinical or trials-based research – as a high priority. Some societies are perhaps more akin to social gatherings. Second, many suffer from a lack of funding and feel unable or unwilling to increase their membership fees to support development into research networks. Third, and perhaps most surprisingly, some feel that becoming part of a wider research effort is itself a threat to their autonomy. They perceive a danger that closer co-operation with other national institutions such as NHS R & D in the manner proposed will mean that NHS R & D ‘sets the agenda’ for the society: their constituent members will ‘lose control’. My personal view is that it will work the other way: evolving into a network will mean that the society will be able to exploit the opportunities offered by NHS R & D to become stronger and more influential [4]. Finally, network-based or multicentre work requires close co-operation between members and groups. Identifying a single priority or a few research questions inevitably means that those whose work falls outside the defined scope may feel excluded. As intense competition for limited funding has hitherto been ‘the norm’ in our specialty, the more consensual approach needed to start a national network will require a huge cultural shift from us all. Fortunately, many societies seem to have embraced the network concept. Even a cursory glance at the website of the Intensive Care Society (http://www.ics.ac.uk) makes clear the impressive efforts of that group to address key questions in clinical research in a manner that conforms to the expectations of NHS R & D; and the achievements of the Intensive Care National Audit and Research Centre (ICNARC) are well-established (http://www.icnarc.org) [4]. Shorten concludes: ‘…clinical anaesthetists are observant and practical. We recognise the problems that matter…’. To translate these sentiments into the reality of a network will require every anaesthetist in a specialist society to ask: First, ‘what are the key questions in our field, the answers to which will really matter to patient care?’ Second, ‘how do we, as a specialist society, best find an answer to these questions?
No takes yet. Share an insight, caveat, or question.
Jaideep J. Pandit (2007) conducted an editorial in Anaesthesia and translational research. Evolution of specialist societies into national research networks was evaluated. The evolution of specialist societies into national research networks is proposed as a solution to the translation problem in anaesthetic research, despite cultural and funding barriers.
Synapse has enriched 10 related papers. Consider them for comparative context: